Eupraxia Pharmaceuticals Inc.
EPRXF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $26 | $25 | $21 | $0 |
| Short-Term Investments | $0 | $0 | $9 | $0 |
| Receivables | $0 | $0 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $26 | $25 | $31 | $1 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $1 | $1 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $27 | $26 | $31 | $1 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $14 | $0 | $0 | $13 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $12 | $4 | $2 | $10 |
| Total Curr. Liab. | $26 | $4 | $2 | $23 |
| LT Debt | $0 | $10 | $9 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $10 | $9 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $26 | $15 | $12 | $23 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $3 | $0 | $0 |
| Common Stock | $123 | $92 | $81 | $24 |
| Retained Earnings | -$139 | -$97 | -$74 | -$51 |
| AOCI | -$4 | -$3 | $0 | $0 |
| Other Equity | $23 | $18 | $14 | $6 |
| Total Equity | $3 | $13 | $20 | -$21 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$2 | -$1 | -$1 | -$0 |
| Total Liab. & Tot. Equity | $27 | $26 | $31 | $1 |
| Net Debt | -$12 | -$14 | -$11 | $13 |